Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Immunologic Research
Published in: Immunologic Research 1/2017

01-02-2017 | GUEST EDITORIAL

Novel clinical and therapeutic aspects in autoimmunity

Authors: Howard Amital, Abdulla Watad, Zoltán Szekanecz

Published in: Immunologic Research | Issue 1/2017

Login to get access

Excerpt

The Autoimmunity Congress has become a tradition and an important biannual event in the world of autoimmunity. …
Literature
1.
Meroni PL, Valentini G, Ayala F, Cattaneo A, Valesini G. New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: a systematic analysis. Autoimmun Rev. 2015;14(9):812–29.CrossRefPubMed
2.
Deehan M, Garcês S, Kramer D, Baker MP, Rat D, Roettger Y, Kromminga A. Managing unwanted immunogenicity of biologicals. Autoimmun Rev. 2015;14(7):569–74.CrossRefPubMed
3.
Ogrič M, Terčelj M, Praprotnik S, et al. Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis—a comprehensive overview of methodology pitfalls and benefits. Immunol Res. 2016. doi:10.​1007/​s12026-016-8824-8.PubMed
4.
Audemard-Verger A, Pillebout E, Guillevin L, Thervet E, Terrier B. IgA vasculitis (Henoch-Shönlein purpura) in adults: diagnostic and therapeutic aspects. Autoimmun Rev. 2015;14(7):579–85.CrossRefPubMed
5.
6.
7.
Wu H, Zhao M, Tan L, Lu Q. The key culprit in the pathogenesis of systemic lupus erythematosus: aberrant DNA methylation. Autoimmun Rev. 2016;15(7):684–9.CrossRefPubMed
8.
Marinho A, Carvalho C, Boleixa D, et al. Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohort. Immunol Res. 2016. doi:10.​1007/​s12026-016-8829-3.PubMed
9.
10.
11.
Abreu MM, Danowski A, Wahl DG, Amigo MC, Tektonidou M, Pacheco MS, et al. The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on antiphospholipid antibodies technical task force report on antiphospholipid syndrome clinical features. Autoimmun Rev. 2015;14(5):401–14.CrossRefPubMed
12.
Hassan M. Noureldine A, Haydar AA, et al. Antiphospholipid syndrome (aps) revisited: would migraine headaches be included in future classification criteria? Immunol Res. 2016.. doi:10.​1007/​s12026-016-8831-9.
13.
14.
15.
Patuzzo G, Barbieri A, Tinazzi E, Veneri D, Argentino G, Moretta F, Puccetti A, Lunardi C. Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev. 2016;15:877-82.CrossRefPubMed
16.
17.
Shovman O, Gilburd B, Chayat C, et al. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune mediated necrotizing myopathy following statin exposure. Immunol Res. 2016. doi:10.​1007/​s12026-016-8867-x.PubMed
18.
Pellegrino P, Clementi E, Radice S. On vaccine’s adjuvants and autoimmunity: current evidence and future perspectives. Autoimmun Rev. 2015;14(10):880–8.CrossRefPubMed
19.
20.
Balbi GGM, Montes RA, Vilela VS, et al. Rapidly progressive diffuse systemic sclerosis after local vitamins A, D and E complex injections: literature review and report of two cases. Immunol Res. 2016. doi:10.​1007/​s12026-016-8851-5.PubMed
21.
Valentini G. Undifferentiated Connective tissue disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc). Autoimmun Rev. 2015;14(3):210–3.CrossRefPubMed
22.
Infantino M, Meacci F, Grossi V, et al. The clinical impact of anti-DFS70 antibodies in undifferentiated connective tissue disease: case reports and a review of the literature. Immunol Res. 2016. doi:10.​1007/​s12026-016-8836-4.
23.
Houri Levi E, Watad A, Whitby A, Tiosano S, Comaneshter D, Cohen AD, Amital H. Coexistence of ischemic heart disease and rheumatoid arthritis patients—a case control study. Autoimmun Rev. 2016;15(4):393–6.CrossRefPubMed
24.
Metadata
Title
Novel clinical and therapeutic aspects in autoimmunity
Authors
Howard Amital
Abdulla Watad
Zoltán Szekanecz
Publication date
01-02-2017
Publisher
Springer US
Published in
Immunologic Research / Issue 1/2017
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-016-8856-0

Other articles of this Issue 1/2017

Immunologic Research 1/2017 Go to the issue

Therapeutic Aspects in Autoimmunity

The clinical impact of Anti-DFS70 antibodies in undifferentiated connective tissue disease: case reports and a review of the literature

Therapeutic Aspects in Autoimmunity

Glaucoma: recent advances in the involvement of autoimmunity

Mechanism in Autoimmunity

A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist’s office

Environment and Autoimmunity

Is explantation of silicone breast implants useful in patients with complaints?

Therapeutic Aspects in Autoimmunity

Detection of adalimumab and anti-adalimumab antibodies in patients with rheumatoid arthritis: a comprehensive overview of methodology pitfalls and benefits

Therapeutic Aspects in Autoimmunity

Hepatitis B carrier state among SLE patients: case–control study